SM
CBPO

Sabby Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Sabby Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-20,000
Closed -$1.8M – 412
2015
Q3 		$1.8M Buy
20,000
+15,000
+300% +$1.58M 0.07% 168
2015
Q2 		$576K Buy
+5,000
New +$525K 0.02% 253

Other funds holding CBPO

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sabby Management's CBPO Position: Q4 2015 in Review

Sabby Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2015, closing a stake of 20,000 shares — an estimated $1.8M sold.

Sabby Management first reported a position in CBPO in Q2 2015 and held it in 2 quarters. The position peaked at $1.8M in Q3 2015. 114 funds tracked by Wall St. Rank hold CBPO as of Q4 2015.

  • Sabby Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2015 after selling out during the quarter.
  • Sabby Management sold 20,000 China Biologic Products Holdings, Inc. shares in Q4 2015, an estimated $1.8M.
  • Sabby Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 2 quarters.
  • Sabby Management's China Biologic Products Holdings, Inc. position peaked at $1.8M in Q3 2015.
  • 114 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2015.

Based on Sabby Management's 13F filing for Q4 2015, filed 16 Feb 2016.